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Abstract
Background: The atherosclerotic process at the endothelial level begins in early ages and seems to be associated with 
obesity and its comorbidities as insulin resistance.
Objective: The aim of this study was to verify the influence of insulin resistance on inflammatory and subclinical markers 
of atherosclerosis in obese adolescents. 
Methods: Sixty-six post-pubescent obese adolescents were divided in two groups according to homeostasis model 
assessment of insulin resistance (HOMA-IR) measurement: with insulin resistance (IR) n=39 and without insulin 
resistance (NIR) n=27, and submitted to an interdisciplinary intervention over the course of 1 year. Common carotid 
artery intima-media thickness (cIMT), visceral and subcutaneous adipose tissue was determined by ultrasound. 
Body composition, blood pressure, HOMA-IR, lipid profile and adipokines concentrations [leptin, adiponectin, and 
plasminogen activator inhibitor type (PAI-1)] were analyzed before and after the therapy.
Results: Both groups presented significant improvements in body composition, inflammatory state (reduction of leptin and 
PAI-1 concentration; increasing of plasma adiponectin) and reduction of cIMT. Only NIR group showed positive correlation 
between changes in visceral fat (∆Visceral) and changes in cIMT (∆ cIMT) (r = 0.42; p < 0.05). Simple linear regression 
analyze revealed ∆Visceral to be an independent predictor to reduction of cIMT in this group (R2 adjusted = 0.14, p = 0.04). 
The final values of cIMT remained significantly higher in IR group when compared to NIR group.
Conclusion: The presence of insulin resistance can impair changes in cIMT leading to early development of atherosclerosis 
in obese adolescents submitted to an interdisciplinary intervention. (Arq Bras Cardiol 2012;99(4):892-898)
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Introduction 
Carotid intima media thickness (cIMT) measurement is 
a marker of subclinical atherosclerosis and its increase has 
been associated with the presence of risk factors such as 
hypertension, dyslipidemia, diabetes, and obesity1,2. Some 
studies have shown that the atherosclerotic process at the 
endothelial level begins in early ages3,4. There are evidences 
that cIMT is higher in children with obesity than in healthy 
controls, and the effects of childhood obesity on the adult 
vasculature are cumulative1,3,5.
Obesity is the most prevalent pathophysiological cause 
of insulin resistance (IR) that is defined as a decreased tissue 
response to insulin-mediated cellular actions, referring 
to whole-body reduced glucose uptake in response to 
physiological insulin concentration6,7.
Moreover, the adipose tissue, mainly the visceral fat, is 
related to an increase in cardiovascular risk and morbimortality 
besides producing several pro-inflammatory adipokines 
including leptin and plasminogen activator inhibitor type 1 
(PAI-1) which play important regulatory functions in a variety 
of biological processes, including atherosclerosis, apart from 
their role in IR6,8-12.
Studies involving different kinds of interventions 
(pharmacological, nutritional, lifestyle changes) have 
shown significant results in reducing cIMT in children and 
adolescents13-16. Previous study of our group demonstrated 
that the improvement of IR was an independent predictor 
to reduce cIMT in obese adolescents submitted to an 
interdisciplinary intervention over the course of 1 year14. 
However, the role of biomarkers associated with insulin 
resistance and obesity in both the development and treatment 
of subclinical atherosclerosis is not well elucidated.
Therefore, the aim of the present study was to verify 
whether the presence of insulin resistance exerts influence on 
response and association among inflammatory and subclinical 
markers of atherosclerosis in obese adolescents submitted to 
1 year of interdisciplinary intervention.
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protocol involved repeated manual measurements of the right 
and left common carotid far wall at 2 cm proximal to the bulb 
bifurcation. On a longitudinal B-mode image, the far wall of 
the common carotid artery appears as two bright parallel lines 
separated by a hypoechoic space. The distance between the 
leading edge of the first bright line on the far wall (lumen–
intima interface) and the leading edge of the second bright line 
(media–adventitia interface) indicates the cIMT of the far wall 
as previously described21. Three measurements of the left and 
right common carotid were taken and the mean the higher 
measures of each side represented the cIMT in this study2.
Serum analysis
Blood samples were collected at the outpatient clinic 
around 8 a.m. after
overnight fast. After collection, the blood was centrifuged 
for 10 min at 5,000 r.p.m. and stored at −70°C for future 
analyses. The materials used for collection were disposable, 
adequately labeled and of recognized quality. Blood was 
collected by a skilled and qualified technician. 
Insulin resistance was assessed by the homeostasis model 
assessment-insulin resistance (HOMA-IR) index and the 
quantitative insulin sensitivity check index (QUICKI). HOMA-
IR was calculated as the product of blood glucose (fasting 
blood glucose) and immunoreactive insulin (I): (fasting blood 
glucose (mg/dl) × I (mU/l)/405). QUICKI was calculated as 
1/(log I + log FBG). The cutoff of HOMA-IR adopted for 
adolescents was 3.1622. 
The leptin, adiponectin and PAI-1 concentrations 
were  measured us ing  a  commerc ia l l y  ava i l ab le 
enzyme-linked immunosorbent assay (ELISA) kit from 
R&D Systems (Minneapolis, USA), according to the 
manufacturer’s instructions. 
Blood pressure
Blood pressure (BP) was measured at least twice on the right 
arm using a mercury-gravity manometer with proper cuff size, 
with the volunteers in the seated position. The first appearance 
of sound (phase 1 Korotkoff sound) was used to define systolic 
BP, and the disappearance of sound (phase 5 Korotkoff 
sound) was used to define diastolic BP14. Hypertension was 
determined by reference values of BP percentiles for gender, 
according to age and height percentile23.
 
Research design 
The interdisciplinary weight loss program combined 
exercise training (aerobic plus resistance training) with clinical, 
nutritional and psychological therapy. All measurements were 
performed before and after one year of intervention.
Clinical therapy
To address the health and clinical parameters, obese 
adolescents visited the endocrinologist once each month. 
Medical follow-up and treatment were based on an initial 
patient and family history, physical examination and 
intervention in any health problems that had developed over 
the course of the therapy.
Methods
Study subjects
A total of 66 post-pubescent17 obese adolescents (BMI > 95th 
percentile on the CDC reference growth charts)18, aged from 
14 to 19 years (16.75 + 1.63 years), including 39 with insulin 
resistance (IR)  and 27 without insulin resistance (NIR), were 
recruited for an interdisciplinary  weight loss program during 
1 year. Hyperleptinemia was defined by leptin baseline values 
above 20 ng/ml for boys and 24 ng/ml for girls, as based on 
reference values cited by Gutin et al. (1999)19. The inclusion 
criteria for the post-pubertal stage were based on the Tanner 
scale (stage five) for both boys and girls. Non-inclusion criteria 
were as follows: other metabolic or endocrine diseases, 
chronic alcohol consumption, previous use of drugs such as 
anabolic-androgenic steroids or psychotropics, which may 
affect appetite regulation, and pregnancy. Informed parental 
consent and the adolescents’ assent to participate as volunteer 
in an interdisciplinary weight loss program were obtained. This 
study was conducted in accordance with the principles of the 
Helsinki Declaration and was formally approved by the ethics 
committee of the Federal University of São Paulo (Number: 
0135/04) and registered in the Clinical trial (NCT01357883).
Anthropometric measurements and body composition 
Volunteers were weighed while wearing light clothing 
and no shoes on a Filizola scale to the nearest 0.1 kg. Height 
was measured to the nearest 0.5 cm with a wall-mounted 
stadiometer (Sanny, model ES 2030). Body mass index (BMI) 
was calculated as body weight divided by height squared 
(wt/ ht2). Body composition was measured by air displacement 
plethysmography in a BOD POD body composition system 
(version 1.69; Life Measurement Instruments, Concord, CA). 
Measurements of visceral and subcutaneous fat
All abdominal ultrasound procedures and measurements 
of visceral and subcutaneous fat were performed by the 
same blinded diagnostic imaging specialist using a 3.5 MHz 
multi-frequency transducer (broad band). This procedure 
allowed a reduction in the risk margin for misclassification. The 
intra-examination coefficient of variation for ultrasound was 
0.8%. Ultrasound measurements of visceral and subcutaneous 
fat were taken. Ultrasound-determined subcutaneous fat was 
defined as the distance between the skin and external face 
of the rectus abdominis muscle, and visceral fat was defined 
as the distance between the internal face of the same muscle 
and the anterior wall of the aorta20.
 
Measurements of carotid artery intima-media thickness
The carotid artery intima-media thickness was measured 
by the same experienced radiologist who was blinded to the 
participant’s laboratory values and risk factor levels, before and 
after intervention, using high-resolution ultrasound equipment 
(Logic 5 and Logic 7, General Electric) with a 7-14 MHz 
linear array transducer. The intra-examination coefficient of 
variation for the cIMT was 4.36%. Patients were examined 
in the supine position with the neck in hyperextension. The 
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Exercise protocol
The combined exercise-training program was performed 
three times per week for 1 year and included 30 minutes of 
aerobic training plus 30 minutes of resistance training per 
session. The subjects were instructed to reverse the order of 
the exercises (aerobic and resistance) at each training session. 
The aerobic training consisted of running on a motor-driven 
treadmill (Life Fitness–Model TR 9700HR) at a cardiac 
frequency intensity representing ventilatory threshold 
I (±4 bpm), according to the results of an initial oxygen uptake 
test for aerobic exercises. The exercise program was based 
on guidelines from the American College of Sports Medicine 
(ACSM), 200924. 
Resistance training was also designed based on ACSM 
recommendations. Exercises targeted each of the main muscle 
groups. All adolescents had 2 weeks for adaptation to training 
to learn the movement (three sets of 15–20RM). After this 
introductory period, the load of training was adjusted and 
each eight weeks volume and intensity were adjusted inversely, 
decreasing the number of repetitions from 15-20 to 10-12 and 
6-8 respectively, for three sets. All sessions were rigorously 
supervised by an experienced physiologist.
Nutritional therapy 
Energy intake was set at levels recommended for subjects 
with low levels of physical activity of the same age and gender, 
following a balanced diet. Once a week, adolescents received 
dietetics lessons covering the topics related to a healthy 
eating pattern.  All patients received individual nutritional 
consultation during the intervention program. At the beginning 
of the study and at 12 months into the program, a 3-day dietary 
record was collected. Because most obese people under-
report their food consumption, each adolescent was asked 
to record their diet with help from their parents. The degree 
of under-reporting may still be substantial; however, this is a 
validated method for the assessment of dietary consumption20. 
These dietary data were transferred to a computer by the same 
dietician and the nutrient composition was analyzed by a PC 
program developed at the Federal University of São Paulo – 
Paulista Medicine School (Nutwin software, for Windows, 
version 1.5, 2002).
Psychological therapy
Psychological therapy treatment plans were established 
based on validated questionnaires taking into account 
some of the psychological problems caused by obesity, as 
described in the literature. These included depression, eating 
disorders, anxiety, decreased self-esteem, and body-image 
disorders. Interdisciplinary therapy consisted of a weekly 
1 h group session. Individualized psychological therapy was 
recommended when weight problems were found.
Statistical analysis
Statistical analyses were performed using STATISTICA 
(version 7.0 for Windows). The Gaussian distribution of 
variables (including ∆ values) was verified with a Kolmogorov 
Smirnov test. Variables with normal distribution were 
expressed as mean ± standard deviation (SD) while variables 
without normal distribution were expressed as median 
[quartile range] in a descriptive table. Analysis of variance for 
repeated measures (ANOVA) was used to compare the data 
from baseline and after therapy between the two groups for 
parametric variables, and Mann-Whitney U test followed by 
Wilcoxon signed rank, for non-parametric variables. Spearman 
correlation coefficients were calculated to assess possible 
relationships between non-normally distributed variables. 
Simple linear regression analysis was used to verify possible 
interrelationships between the measurements. 
Results
Entire group
After 1 year of interdisciplinary intervention, both groups 
presented significant improvements in body composition 
(Table 1) [reduction of total body mass, body mass index (BMI), 
fat body mass (% and kg), visceral and subcutaneous fat and 
increasing lean body mass (%)]; lipid profile (Table 2) (reduction 
of total cholesterol, LDL-cholesterol and triglycerides); and 
inflammatory markers (Table 3) (reduction of leptin and PAI-1 
concentration as well as increasing plasma adiponectin). Leptin/
adiponectin ratio was also reduced (Table 3). 
Both groups presented significant reduction in cIMT 
and increased in QUICKI values, as showed in Tables 3 
and 2, respectively.
Non-insulin resistance group (NIR)
Significant reduction in visceral/subcutaneous fat ratio was 
observed at the end of weight loss therapy. After analyzing 
the correlation between ∆cIMT with changes (∆) in body 
composition, lipid profile and inflammatory factors,  a positive 
correlation was found only between ∆ cIMT and changes 
in visceral fat (∆ visceral) (r = 0.42; p < 0.05). To identify 
possible cause-effect relationship in the correlation found, a 
simple linear regression analyze was performed and revealed 
that ∆Visceral to be an independent predictor to reduction of 
cIMT in this group (R2 adjusted = 0.14, p = 0.04).
Insulin resistance group (IR)
At baseline conditions, this group presented positive 
correlation between cIMT and visceral/subcutaneous fat ratio 
(r = 0.37, p < 0.05), but the cIMT reduction did not associated 
itself with improvement of any variables. 
Significant improvements in insulin concentration, HOMA-
IR, VLDL and lean body mass (kg) were found after 1 year. 
Moreover, the final values of cIMT and QUICKI remained 
significantly higher and lower, respectively, in this group, when 
compared to NIR group. 
  
Discussion
One of the most important finding of this study were 
significant reductions in hyperleptinemia, PAI-1, and leptin/
adiponectin ratio, as well as an increase in adiponectin 
concentration (Table 3) in both groups. High PAI-1 concentration 
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Table 1 - Body composition in both groups before and after interdisciplinary intervention
Without Insulin Resistance (NIR=27) With Insulin Resistance (IR=39)
 Baseline 1 Year ∆ Baseline 1 Year ∆
Total Body Mass (kg) 99.70 ± 12.95 89.68 ± 12.61* -10.02 ± 6.35 110.95 ± 15.90 98.88 ± 17.22* -12.08 ± 8.62
BMI (kg/m2) 36.33 ± 4.78 32.39 ± 4.76* -3.94 ± 2.52 38.46 ± 5.21 33.84 ± 5.58* -4.62 ± 3.13
Fat Body Mass (%) 47.38 ± 5.77 39.94 ± 7.86* -7.44 ± 4.27 47.85 ± 5.55 38.39 ± 7.52* -9.47 ± 4.60
Lean Body Mass (%) 52.62 ± 5.77 60.07 ± 7.85* 7.45 ± 4.25 52.42 ± 5.34 61.61 ± 7.52* 9.28 ± 4.51
Fat Body Mass (kg) 47.60 ± 10.56 36.31 ± 11.08* -11.29 ± 5.62 52.89 ± 11.03 38.55 ± 11.64* -14.48 ± 6.94
Lean Body Mass (kg) 52.09 ± 6.28 53.23 ± 6.03 0.60 ± [-0.70-4.40] 57.71 ± 8.49 60.77 ± 9.66* 1.30 ± [-0.12-6.40]
Visceral fat (cm) 4.13 ± 1.12 2.41 ± 1.00* -1.66 ± 0.77 4.71 ± 1.64 3.23 ± 1.36* -1.51 ± 1.41
Subcutaneous fat (cm) 4.12 ± 0.96 3.09 ± 0.64* -0.97 ± 0.97 4.14 ± 0.89 3.36 ± 0.86* -0.82 ± 0.77
Visc/Subc fat ratio 1.06 ± 0.36 0.82 ± 0.40* -0.23 ± 0.36 1.19 ± 0.49 1.00 ± 0.43 -0.18 ± 0.46
Data expressed as mean ± SD and median [quartile range];
* Difference between baseline and after 1 year (p ≤ 0.05);
p-value obtained by parametric test ANOVA for repeated measures  
BMI-Body mass index
Table 2 - Parameters related to lipid profile, glucose metabolism and blood pressure in both groups before and after interdisciplinary intervention
Without Insulin Resistance (NIR=27) With Insulin Resistance (IR=39)
 Baseline 1 Year ∆ Baseline 1 Year ∆
Total Cholesterol (mg/dL) 163 ± 28 153 ± 26 * -9 ± 12 166 ± 32 155 ± 26* -11 ± 19
LDL-c (mg/dL) 98 ± 23 89 ± 21* -8 ± 14 100 ± 27 91 ± 22* -9 ± 16
HDL-c(mg/dL) 46 ± 10 48 ± 10 2 ± 4 43 ± 8 44 ± 7 1 ± 6
VLDL (mg/dL) 18 ± 8 15 ± 7 -3 ± 6 21 ± 9 18 ± 9* -3 ± 8
Triglycerides (mg/dL) 82 ± [58-113] 65 ± [52-79]* -11 ± [-35-0] 95 ± [71-146] 76 ± [64-102]* -15 ± [-38-5]
Glucose (mg/dL) 87 ± 6 87 ± 5 0 ± 5 91 ± 7 91 ± 8 0 ± 10
Insulin (ìU/dL) 10.53 ± 2.60 8.80 ± 5.34 -3.10 ± [-4.20-0.87] 20.51 ± 6.67 14.13 ± 11.21* -7.30 ± [-9.90--3.90]
HOMA-IR 2.26 ± 0.53 1.93 ± 1.25 -0.74 ± [-0.97-0.34] 4.64 ± 1.62 3.30 ± 3.29* -1.61 ± [-2.60--0.69]
QUICKI 0.34 ± 0.01 0.36 ± 0.03* 0.02 ± 0.03 0.31 ± 0.01 0.33 ± 0.03*† 0.02 ± 0.03
MBP (mmHg) 129 ± [126-129] 83 ± [83- 86]* -44 ± 5 129 ± [126-132] 86 ± [83-93]* -42 ± 7
Data expressed as mean ± SD and median [quartile range];
* Difference between baseline and after 1 year (p≤0.05);
† Difference between final values (p≤0.05);
p-value obtained by parametric test ANOVA for repeated measures  and  non-parametric test Mann-Whitney U test followed by Wilcoxon signed rank;
LDL-c-low-density lipoprotein-cholesterol; HDL-c-high-density lipoprotein-cholesterol;  VLDL-very low-density lipoprotein;  HOMA-IR-homeostasis model assessment 
insulin resistance index; QUICKI-quantitative insulin sensitivity check index;  MBP-Mean Blood Pressure.
is related to increased expression of cellular/vascular adhesion 
molecules and decreased insulin sensitivity, which are 
implicated in the initiation of endothelial dysfunction25,26. On 
the other hand, adiponectin exerts potent anti-inflammatory 
and anti-atherogenic role. Moreover, at the end of therapy 
there was reduction in the prevalence of hyperleptinemia in 
36% (from 100% to 64%) associated to a reduction in 32% 
(from 59% to 27%) in insulin resistance in all analyzed patients 
(data not shown). The attenuation of inflammatory state 
promoted by this interdisciplinary therapy is relevant, once 
the altered concentration of these adipokines participates in 
the inception and progression of atherosclerosis25,27.
In the NIR group, there was a significant reduction of 
visceral/subcutaneous fat ratio. This measure has being 
considered an important index of cardiovascular risk. Visceral 
fat is strongly associated with obesity-related complications like 
Type 2 diabetes and coronary artery disease28,29.
 Another relevant finding in the present investigation was the 
positive correlation between changes in visceral fat (∆Visceral) 
and changes in cIMT (∆ cIMT) verified in this group.  Studies 
have shown that the association between visceral adiposity 
and atherosclerosis development is independent of age, overall 
obesity or the amounts of subcutaneous fat. In addition, visceral 
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adipose tissue and its adipose-tissue resident macrophages 
present increased pro-inflammatory adipokines release and 
less adiponectin28,29. However, it is unclear how much visceral 
fat reduction is needed to induce favorable metabolic changes. 
In this study, a mean reduction of 1.66 ± 0.77 cm in the 
visceral fat thickness presented a positive correlation with 
∆cIMT in the NIR group, suggesting that insulin resistance 
could influence the association between visceral fat and cIMT, 
since this correlation was not found in the IR group. To better 
understand this association, simple regression analysis was 
performed. It was found that change in visceral fat was an 
independent predictor of improvement in cIMT, emphasizing 
the importance to develop strategies to avoid abdominal 
obesity and atherosclerotic disease29. These outcomes also 
suggest that the presence of IR could be contributed to positive 
correlation between cIMT and visceral/subcutaneous fat ratio. 
Although both groups presented reduction on cIMT, it 
is important to observe that, in the IR group, this measure 
maintained significantly higher than in the NIR group, 
reinforcing that the frame of insulin resistance could corroborate 
the early development of atherosclerosis in obese adolescents.
One year of interdisciplinary therapy also promoted a 
significant improvement in body composition independently 
of the presence of insulin resistance (Table 1). These findings 
corroborate with  literature evidences, that demonstrate the 
efficacy of weight loss programs in improving insulin sensitivity 
and avoiding that insulin resistance impair weight loss process 
in obese children and adolescents30,31. 
Conclusions
This study shows that the presence of insulin resistance seems 
influence on response and association among inflammatory 
and subclinical markers of atherosclerosis in obese adolescents 
submitted to an interdisciplinary intervention. Further studies 
are required to better comprehension of mechanisms involved 
in the association among obesity, insulin resistance and 
subclinical atherosclerosis, their early prevention and enhance 
clinical treatment.
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Table 3 - Inflammatory markers and carotid intima-media thickness (cIMT) in both groups before and after interdisciplinary intervention
Without Insulin Resistance (NIR=27) With Insulin Resistance (IR=39)
 Baseline 1 Year ∆ Baseline 1 Year ∆
Leptin (ng/mL) 52.24 ± 24.74 30.36 ± 18.15* -14.99 ± [-30.42--1.89] 51.66 ± 26.68 27.89 ± 19.95* -18.32 ± [-27.71--6.51]
Adiponectin (ìg/L) 4.93 ± [3.72-9.89] 5.53 ± [4.07-10.39]* 1.19 ± 2.83 4.07 ± [3.11-7.49] 4.32 ± [3.72-9.44]* 1.39 ± 2.07
Leptin/Adiponectin ratio 10.45 ± [3.63-17.19] 3.76 ± [2.37-6.65]* -3.08 ± [-10.11--0.94] 10.43 ± [4.83-19.14] 4.60 ± [2.12-7.19]* -5.62 ± [-10.52--2.22]
PAI-1 (ng/mL) 12.69 ± 7.51 9.24 ± 8.31* -3.70 ± 3.42 13.58 ± 8.17 9.11 ± 7.85* -4.47 ± 7.18
Resistin (ng/mL) 14.94 ± 8.07 14.93 ± 7.08 -0.57 ± 3.48 15.84 ± 8.33 16.98 ± 9.11 0.63 ± 5.77
cIMT (mm) 0.40 ± 0.05 0.32 ± 0.04* -0.07 ± 0.05 0.42 ± 0.06 0.37 ± 0.06*† -0.05 ± 0.07
Data expressed as mean ± SD and median [quartile range];
* Difference between baseline and after 1 year (p ≤ 0.05);
† Difference between final values (p ≤ 0.05);
p-value obtained by parametric test ANOVA for repeated measures  and  non-parametric test Mann-Whitney U test followed by Wilcoxon signed rank;
PAI-1=-plasminogen activator inhibitor 1;  cIMT-carotid intima-media thickness.
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